Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential applications. Early findings suggest that this higher dosage may enhance the drug's ability to control blood sugar, potentially offering greater outcomes for individuals with type 2 diabetes. Further study is underway to fully understand the long-term